About PTC Therapeutics
PTC Therapeutics is a company based in South Plainfield (United States) founded in 1998.. PTC Therapeutics has raised $248.1 million across 23 funding rounds from investors including Amgen, Novartis and Credit Suisse. The company has 939 employees as of December 31, 2024. PTC Therapeutics has completed 2 acquisitions, including Agilis Biotherapeutics and Censa Pharmaceuticals. PTC Therapeutics offers products and services including SMA Treatments, DMD Treatments, and PKU Treatments. PTC Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BridgeBio, Spark Therapeutics and Biogen, among others.
- Headquarter South Plainfield, United States
- Employees 939 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ptc Therapeutics, Inc.
-
Annual Revenue
$806.78 M-13.97as on Dec 31, 2024
-
Net Profit
$-363.3 M42.02as on Dec 31, 2024
-
EBITDA
$-71.08 M36.99as on Dec 31, 2024
-
Total Equity Funding
$248.1 M (USD)
in 23 rounds
-
Latest Funding Round
$35.9 M (USD), Post-IPO
May 16, 2023
-
Investors
Amgen
& 23 more
-
Employee Count
939
as on Dec 31, 2024
-
Investments & Acquisitions
Agilis Biotherapeutics
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PTC Therapeutics
PTC Therapeutics is a publicly listed company on the NASDAQ with ticker symbol PTCT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PTC Therapeutics
PTC Therapeutics offers a comprehensive portfolio of products and services, including SMA Treatments, DMD Treatments, and PKU Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medications for spinal muscular atrophy to enhance motor function.
Therapies for Duchenne muscular dystrophy to slow progression.
Solutions for phenylketonuria to manage metabolic issues.
Unlock access to complete
Unlock access to complete
Leadership Team
63 people
Software Development Team
40 people
Finance and Accounting
26 people
Operations Team
26 people
Product Management Team
13 people
Regional Team
11 people
Legal and Compliance
9 people
Senior Team
9 people
Unlock access to complete
Funding Insights of PTC Therapeutics
PTC Therapeutics has successfully raised a total of $248.1M across 23 strategic funding rounds. The most recent funding activity was a Post-IPO round of $35.9 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 23
- Last Round Post-IPO — $35.9M
-
First Round
First Round
(19 Sep 2001)
- Investors Count 24
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Post-IPO - PTC Therapeutics | Valuation |
investors |
|
| May, 2020 | Amount | Post-IPO - PTC Therapeutics | Valuation |
investors |
|
| Sep, 2019 | Amount | Post-IPO - PTC Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PTC Therapeutics
PTC Therapeutics has secured backing from 24 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, Novartis and Credit Suisse. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in Asia and Europe
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward healthcare companies by Longwood Fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PTC Therapeutics
PTC Therapeutics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Agilis Biotherapeutics and Censa Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drugs for Tetrahydrobiopterin deficiency and rare CNS disorders are developed.
|
2015 | ||||
|
Gene therapy platform for rare monogenic CNS diseases is developed.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - PTC Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ptc Therapeutics Comparisons
Competitors of PTC Therapeutics
PTC Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BridgeBio, Spark Therapeutics and Biogen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ptc Therapeutics
Frequently Asked Questions about PTC Therapeutics
When was PTC Therapeutics founded?
PTC Therapeutics was founded in 1998 and raised its 1st funding round 3 years after it was founded.
Where is PTC Therapeutics located?
PTC Therapeutics is headquartered in South Plainfield, United States. It is registered at South Plainfield, New Jersey, United States.
Is PTC Therapeutics a funded company?
PTC Therapeutics is a funded company, having raised a total of $248.1M across 23 funding rounds to date. The company's 1st funding round was a Post-IPO of $250M, raised on Sep 19, 2001.
How many employees does PTC Therapeutics have?
As of Dec 31, 2024, the latest employee count at PTC Therapeutics is 939.
What is the annual revenue of PTC Therapeutics?
Annual revenue of PTC Therapeutics is $806.78M as on Dec 31, 2024.
What does PTC Therapeutics do?
PTC Therapeutics was founded in 1998 and is headquartered in South Plainfield, United States. Focus is placed on the development of small molecule drugs targeting rare diseases, with operations centered in the biotechnology sector. The lead product, Ataluren, is administered orally to address cystic fibrosis and Duchenne muscular dystrophy linked to nonsense mutations. Additional efforts are directed toward anticancer and antibacterial therapeutics.
Who are the top competitors of PTC Therapeutics?
PTC Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Spark Therapeutics.
What products or services does PTC Therapeutics offer?
PTC Therapeutics offers SMA Treatments, DMD Treatments, and PKU Treatments.
Is PTC Therapeutics publicly traded?
Yes, PTC Therapeutics is publicly traded on NASDAQ under the ticker symbol PTCT.
How many acquisitions has PTC Therapeutics made?
PTC Therapeutics has made 2 acquisitions, including Agilis Biotherapeutics, and Censa Pharmaceuticals.
Who are PTC Therapeutics's investors?
PTC Therapeutics has 24 investors. Key investors include Amgen, Novartis, Credit Suisse, Manulife, and HHS.
What is PTC Therapeutics's ticker symbol?
The ticker symbol of PTC Therapeutics is PTCT on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.